[go: up one dir, main page]

MC1766A1 - Procede pour la preparation de 3'-azido-nucleosides et procede pour preparer des formulations pharmaceutiques les contenant - Google Patents

Procede pour la preparation de 3'-azido-nucleosides et procede pour preparer des formulations pharmaceutiques les contenant

Info

Publication number
MC1766A1
MC1766A1 MC861847A MC1847A MC1766A1 MC 1766 A1 MC1766 A1 MC 1766A1 MC 861847 A MC861847 A MC 861847A MC 1847 A MC1847 A MC 1847A MC 1766 A1 MC1766 A1 MC 1766A1
Authority
MC
Monaco
Prior art keywords
group
formula
compound
azido
active ingredient
Prior art date
Application number
MC861847A
Other languages
English (en)
French (fr)
Inventor
Rideout Janet
Barry David
Lehran Sandra
St Clair Martha
Furman Phillip
Freeman George
Zimmerman Thomas
Wolberg Gerald
De Miranda Paulo
Shaver Sammy
White Geoffrey
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/776,899 external-priority patent/US4724232A/en
Priority claimed from GB858523878A external-priority patent/GB8523878D0/en
Priority claimed from GB868608272A external-priority patent/GB8608272D0/en
Priority claimed from GB868615322A external-priority patent/GB8615322D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC1766A1 publication Critical patent/MC1766A1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MC861847A 1985-09-17 1986-09-15 Procede pour la preparation de 3'-azido-nucleosides et procede pour preparer des formulations pharmaceutiques les contenant MC1766A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US06/776,899 US4724232A (en) 1985-03-16 1985-09-17 Treatment of human viral infections
GB858523878A GB8523878D0 (en) 1985-09-27 1985-09-27 Therapeutic compounds
GB868608272A GB8608272D0 (en) 1986-04-04 1986-04-04 Antiviral combination
US87779686A 1986-06-23 1986-06-23
GB868615322A GB8615322D0 (en) 1986-06-23 1986-06-23 Antiviral combinations

Publications (1)

Publication Number Publication Date
MC1766A1 true MC1766A1 (fr) 1987-07-17

Family

ID=27516614

Family Applications (1)

Application Number Title Priority Date Filing Date
MC861847A MC1766A1 (fr) 1985-09-17 1986-09-15 Procede pour la preparation de 3'-azido-nucleosides et procede pour preparer des formulations pharmaceutiques les contenant

Country Status (2)

Country Link
ES (2) ES2002342A6 (es)
MC (1) MC1766A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Also Published As

Publication number Publication date
ES2002342A6 (es) 1988-08-01
ES2006672A6 (es) 1989-05-01

Similar Documents

Publication Publication Date Title
US5234913A (en) Antiviral nucleoside combination
AU595832B2 (en) Therapeutic nucleosides
KR100398923B1 (ko) 모노시클릭 ｌ-누클레오시드, 이의 유사체 및 이들의 용도
EP0666749B1 (en) ENANTIOMERICALLY PURE beta-D-DIOXOLANE NUCLEOSIDES WITH SELECTIVE ANTI-HEPATITIS B VIRUS ACTIVITY
DE69933860T2 (de) 2'-fluoronukleoside
MC1742A1 (fr) Procede pour preparer un derive de 3'-azido-3'desoxythymigline et procede pour preparer une formulation pharmaceutique le contenant
AU613659B2 (en) Antiviral compounds
CN1216893C (zh) 具有抗乙型肝炎病毒活性的核苷
JPH04226999A (ja) 抗ウイルス剤
HU204839B (en) Process for producing pharmaceutical compositions against viruses causing immune deficiency
US5064946A (en) Therapeutic nucleosides
JP2523527B2 (ja) ３′−アジド−ヌクレオシド類、それらの製造法、およびそれらからなる抗ビ−ルス剤
MC1766A1 (fr) Procede pour la preparation de 3'-azido-nucleosides et procede pour preparer des formulations pharmaceutiques les contenant
HU201953B (en) Process for producing new nucleoside derivatives and pharmaceutical compositions comprising same as active ingredient
US20060217345A1 (en) Beta-L-nucleosides and use thereof as pharmaceutical agents for the treatment of viral diseases
AP90A (en) Therapeutic nucleosides.
FI90664B (fi) Menetelmä terapeuttisesti käyttökelpoisten 3'-atsido nukleosidien valmistamiseksi
HK1004189B (en) Antiviral nucleoside combination

Legal Events

Date Code Title Description
YP Annual fee paid